Nanexa CEO invited as speaker at CRS 2022 Annual Meeting
Nanexa AB today announced that CEO David Westberg has been invited as speaker and the company also got three abstracts approved for publication as posters at CRS 2022 Annual Meeting and Expo, on July 11-15, 2022, in Montreal, Canada.
CRS (Controlled Release Society Annual Meeting) is a large international conference gathering leaders in drug development and business development from most of the larger global pharma companies.
“This year, we will present three posters describing PharmaShell® from different perspectives, and we have also been invited as speakers at the conference. I really look forward to presenting PharmaShell and Nanexa to this audience and hope to establish many new contacts during the conference”, said David Westberg, CEO of Nanexa.